T1	Participants 303 362	patients with HF with normal EFs (>50%; i.e., diastolic HF)
T2	Participants 460 643	185 patients with systolic HF (79% men, mean age 62.6 +/- 10.9 years) and 43 with diastolic HF (54% men, mean age 67.4 +/- 9.8 years) enrolled in a phase II multicenter clinical trial
T3	Participants 1101 1135	Patients in the diastolic HF group
